Anifrolumab Malignancy and Serious Infections Study

Clinical trial NCT07000110 · RECRUITING

Trial details

NCT number: NCT07000110
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2026-01-26
Primary completion: 2031-11-30
Enrollment: 3506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.